InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Jindal Vineet R., Chief Financial Officer. Director active across 1 companies, notably Reneo Pharmaceuticals, Inc.. Aggregated, 4 reports have been logged. Total volume traded: €63k. The latest transaction was filed on 10 December 2021 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
030,000 shares0
Common Stock
SEC:0001209191-21-069448·
030,000 shares0
Common Stock
SEC:0001209191-21-069448:0·
€31,5745,000 shares@ €6.3148100.0% of flow
Common Stock
SEC:0001209191-21-053523·
Ideal exit: 22 May 2022 (T+270)
€31,5745,000 shares@ €6.314850.0% of flow
Common Stock
SEC:0001209191-21-053523:0·
Ideal exit: 22 May 2022 (T+270)
4 of 4 declarations
About Jindal Vineet R.
Vineet R. Jindal is the Chief Financial Officer of Reneo Pharmaceuticals, Inc. He oversees the financial operations and funding strategy of the company.
